1. The Role of Drug Exposure in Clinical Development: To What Extent Is Pharmacokinetic Assessment Needed in a Drug Development Programme?

   • Navin Goyal

   Commentary 27 May 2015 Pages: 985 - 987

2. Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer

   • Paul R. Hutson

   Commentary 16 June 2015 Pages: 989 - 991

3. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients

   • Christine E. Staatz
   • Susan E. Tett

   Review Article 03 June 2015 Pages: 993 - 1025

   

4. Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor

   • Damayanthi Devineni
   • David Polidori

   Review Article 04 June 2015 Pages: 1027 - 1041

   

5. Clinical Pharmacokinetic Studies of Enzalutamide

   • Jacqueline A. Gibbons
   • Taoufik Ouatas
   • Joyce Mordenti

   Original Research Article Open access 28 April 2015 Pages: 1043 - 1055

   

6. Pharmacokinetic Drug Interaction Studies with Enzalutamide

   • Jacqueline A. Gibbons
   • Michiel de Vries
   • Taoufik Ouatas

   Original Research Article Open access 01 May 2015 Pages: 1057 - 1069

   

7. Population Pharmacokinetics of ABT-806, an Investigational Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody, in Advanced Solid Tumor Types Likely to Either Over-Express Wild-Type EGFR or Express Variant III Mutant EGFR

   • Shringi Sharma
   • Rajendar K. Mittapalli
   • Hao Xiong

   Original Research Article 12 March 2015 Pages: 1071 - 1081

   

8. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose

   • Nieves Velez de Mendizabal
   • Ricardo Jimenez-Mendez
   • Bruce C. Carleton

   Short Communication 13 March 2015 Pages: 1083 - 1090